Cargando…
Inhibition of SARS–CoV-2 by type I and type III interferons
The recently emerged severe acute respiratory syndrome coronavirus-2 (SARS–CoV-2) is the causative agent of the devastating COVID-19 lung disease pandemic. Here, we tested the inhibitory activities of the antiviral interferons of type I (IFN-α) and type III (IFN-λ) against SARS–CoV-2 and compared th...
Autores principales: | Felgenhauer, Ulrike, Schoen, Andreas, Gad, Hans Henrik, Hartmann, Rune, Schaubmar, Andreas R., Failing, Klaus, Drosten, Christian, Weber, Friedemann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549028/ https://www.ncbi.nlm.nih.gov/pubmed/32587093 http://dx.doi.org/10.1074/jbc.AC120.013788 |
Ejemplares similares
-
Omicron variant of SARS-CoV-2 exhibits an increased resilience to the antiviral type I interferon response
por: Shalamova, Lyudmila, et al.
Publicado: (2022) -
Type I and III interferons disrupt lung epithelial repair during recovery from viral infection
por: Major, Jack, et al.
Publicado: (2020) -
Guarding the frontiers: the biology of type III interferons
por: Wack, Andreas, et al.
Publicado: (2015) -
Species Specificity of Type III Interferon Activity and Development of a Sensitive Luciferase-Based Bioassay for Quantitation of Mouse Interferon-λ
por: Jacobs, Sophie, et al.
Publicado: (2018) -
Bunyaviruses and the Type I Interferon System
por: Elliott, Richard M., et al.
Publicado: (2009)